Licensing MedMira's Rapid Flow-through Technology

MedMira is committed to building strong, mutually beneficial relationships with our industry colleagues to develop new business opportunities and innovations.  MedMira enjoys collaborations with a growing number of diagnostics companies worldwide that share MedMira’s vision of delivering next-generation diagnostics to the global healthcare market.

MedMira can help lower the barriers to new product market entry that are faced by many industry colleagues by enabling commercialization of their rapid test concepts and products using our RFT platform.  The global diagnostics marketplace, particularly in the most lucrative markets of North America and Europe, is complicated by the numerous patents that govern the lateral flow platform.  MedMira, through straightforward and affordable licensing agreements is eliminating many of the intellectual property roadblocks other developers are facing on their way to market.   Partners license and use MedMira’s patented rapid flow-through technology (RFT) platform in the development, manufacturing, and commercialization of new rapid tests. 

If you are interested in accessing MedMira’s RFT technology, please contact us at rft@medmira.com.

 RFT One Sheet